Compound betamethasone Injection(Gluteal muscle injection)
Druggluteal injection of 1 ml of Compound betamethasone and 4 ml of normal saline at week 0,2,4
NCT Number: NCT06626568
The goal of this multicenter pilot study is to validate the effectiveness of extending the injection interval between betamethasone doses from one to two weeks for treating frozen shoulder (adhesive capsulitis) in adults aged 18 to 75. This study also aims to screen potential study centers and gather data to refine the sample size calculation for a larger, future trial. The main questions it aims to answer are:
* Does extending the interval between injections maintain effectiveness in improving shoulder function and reducing pain for frozen shoulder? * Which centers in this pilot study are qualified for a larger, future trial? * What is the appropriate sample size for conducting a multicenter RCT study with the same research design at the selected centers?
Participants will:
* Receive 3 injections over 4 weeks and will be followed up for another 8 weeks * Complete shoulder function assessments * Perform home rehabilitation exercises
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 2
Guangde County People's Hospital, Xuancheng, Anhui, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
gluteal injection of 1 ml of Compound betamethasone and 4 ml of normal saline at week 0,2,4
ultrasound-guided subacromial injection of 1 ml of Compound betamethasone and 4 ml of normal saline at week 0,2,4.
ultrasound-guided subacromial injection of 5 ml of normal saline at week 0,2,4.
gluteal injection of 5 ml normal saline at week 0,2,4.
The participants were instructed to perform home rehabilitation exercise for 12 weeks. 30 minutes of home-based self-rehabilitation exercises in the morning, afternoon, and evening, with a total of 90 minutes per day. Standard instructional videos and demonstrations by outpatient rehabilitation therapists are provided to participants. Each exercise, including wall-climbing, table-climbing, and back-climbing, should be performed for 10 minutes, with a total of 30 minutes per session.
Time frame: Baseline and 12 weeks
The SPADI score ranges from 0 to 100. A score of 0 indicates no pain or disability, while a score of 100 reflects the worst possible pain and maximum functional disability in the shoulder.
Data entry will be performed by blinded research staff. They will present the paper CRF sample form to the participants and ask questions one by one, directly entering the responses of participants into the corresponding electronic CRF form in the EDC system using handheld electronic devices (such as smartphones, tablets, or laptops).
Time frame: From enrollment to the end of follow-up at 12 weeks
Third-party experts will conduct blinded readings of shoulder MRI scans, classifying rotator cuff status into three grades: Grade I (intact), Grade II (partial tear), and Grade III (complete tear). Patients classified as Grade III at week 0 will be excluded from the study, as baseline grading (determined by each research center) assesses eligibility per exclusion criterion 2. The lead center provided MRI reading training to all centers, using T2-weighted images with a pure white fluid signal occupying full or partial thickness of the rotator cuff across at least two consecutive MRI slices as the diagnostic criterion for full- or partial-thickness tears. Patients with Grade I or II tears at week 0 will receive study treatment and be followed up at week 12. Tear progression is defined as an increase of at least one grade between weeks 0 and 12, assessed by blinded experts. The progression rate is the number of subjects with progression divided by the total number in each group.
Time frame: Baseline and 12 weeks
The QuickDASH score ranges from 0 to 100. A score of 0 means no disability, and a score of 100 signifies the highest level of disability related to arm, shoulder, and hand function.
Data entry will be performed by blinded research staff. They will present the paper CRF sample form to the participants and ask questions one by one, directly entering the responses of participants into the corresponding electronic CRF form in the EDC system using handheld electronic devices (such as smartphones, tablets, or laptops).
Time frame: Baseline and 12 weeks
The NRS score ranges from 0 to 10. A score of 0 indicates no pain, while a score of 10 reflects the worst possible pain.
Data entry will be performed by blinded research staff. They will present the paper CRF sample form to the participants and ask questions one by one, directly entering the responses of participants into the corresponding electronic CRF form in the EDC system using handheld electronic devices (such as smartphones, tablets, or laptops).
Time frame: Baseline and 12 weeks
The EQ-5D-5L provides an overall health utility score ranging from -0.281 to 1, where 1 represents perfect health, zero represents a state equivalent to death, and negative values indicate health states worse than death.
It also reports on five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each rated on five levels from no problems to extreme problems.
Data entry will be performed by blinded research staff. They will present the paper CRF sample form to the participants and ask questions one by one, directly entering the responses of participants into the corresponding electronic CRF form in the EDC system using handheld electronic devices (such as smartphones, tablets, or laptops).
Time frame: Baseline and 12 weeks
The passive range of motion for shoulder flexion, abduction, internal rotation (at the side), and external rotation (at the side) on the affected side will be measured using a goniometer by trained researchers following a pre-established standard operating procedure.
Time frame: Baseline
The costs of healthcare resources used for the diagnosis and treatment of frozen shoulder of the participant, including medication fees, medical expenses, testing fees, nursing fees and hospitalization costs. The questionnaire surveys the cost by the participant since the onset of frozen shoulder.
Time frame: Baseline and week2
The costs of healthcare resources used for the diagnosis and treatment of frozen shoulder of the participant, including medication fees, medical expenses, testing fees, nursing fees and hospitalization costs. The questionnaire surveys the cost by the participant since the last outpatient research follow-up.
Time frame: Week2 and week4
The costs of healthcare resources used for the diagnosis and treatment of frozen shoulder of the participant, including medication fees, medical expenses, testing fees, nursing fees and hospitalization costs. The questionnaire surveys the cost by the participant since the last outpatient research follow-up.
Time frame: Week4 and week8
The costs of healthcare resources used for the diagnosis and treatment of frozen shoulder of the participant, including medication fees, medical expenses, testing fees, nursing fees and hospitalization costs. The questionnaire surveys the cost by the participant since the last outpatient research follow-up.
Time frame: Week8 and week12
The costs of healthcare resources used for the diagnosis and treatment of frozen shoulder of the participant, including medication fees, medical expenses, testing fees, nursing fees and hospitalization costs. The questionnaire surveys the cost by the participant since the last outpatient research follow-up.
Time frame: Week 0
The questionnaire surveys the number of workdays missed since the onset of frozen shoulder is collected at baseline.
Time frame: Week 0 and Week 2
The questionnaire surveys the number of workdays missed by the subject since the last outpatient research follow-up.
Time frame: Week 2 and Week 4
The questionnaire surveys the number of workdays missed by the subject since the last outpatient research follow-up.
Time frame: Week 4 and Week 8
The questionnaire surveys the number of workdays missed by the subject since the last outpatient research follow-up.
Time frame: Week 8 and Week 12
The questionnaire surveys the number of workdays missed by the subject since the last outpatient research follow-up.
Time frame: Week 2
This questionnaire surveys the usage of unplanned concomitant analgesic medications by the subject since the last outpatient research follow-up.
Time frame: Week 4
This questionnaire surveys the usage of unplanned concomitant analgesic medications by the subject since the last outpatient research follow-up.
Time frame: Week 8
This questionnaire surveys the usage of unplanned concomitant analgesic medications by the subject since the last outpatient research follow-up.
Time frame: Week 12
This questionnaire surveys the usage of unplanned concomitant analgesic medications by the subject since the last outpatient research follow-up.
Time frame: week 0 and week 12
Depending on the specific assay methods used by the laboratory departments of different study centers, HbA1c will be measured by high-Performance Liquid Chromatography (HPLC), Immunoturbidimetric Method, Enzymatic Method, Affinity Chromatography, Electrophoresis, Capillary Electrophoresis or Ion-Exchange Chromatography.
Time frame: week 0 and week 4
Depending on the specific assay methods used by the laboratory departments of different study centers, glycated albumin will be measured by Enzymatic Method, Immunoturbidimetric Method, High-Performance Liquid Chromatography (HPLC), Affinity Chromatography, or Immunoelectrophoresis.
Time frame: From enrollment to the end of follow-up at 12 weeks
The incidence of serious adverse events (SAE) at 12 weeks
Time frame: From enrollment to the end of follow-up at 12 weeks
The incidence of adverse events (AE) at 12 weeks
Second Affiliated Hospital, School of Medicine, Zhejiang University
Other
Comparison Between Ultrasound Guided Subacromial and Systemic Injection of Steroid for Frozen Shoulder: a Double Blind Multicenter Pilot Study for Randomized Control Trial
Acronym: CUSIS-FS-Pilot
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731646
Adhesive Capsulitis of the Shoulder, Bursitis
Izmir, İzmir, Turkey (Türkiye)
View Trial DetailsNCT07723755
Adhesive Capsulitis, Bursitis
Taipei, Taiwan
View Trial DetailsNCT04806191
Arthralgia, Bursitis
Haugesund, Vestland, Norway
View Trial DetailsNCT07570095
Adhesive Capsulitis, Bursitis
Taipei, Taiwan
View Trial Details